Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.6K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.6K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

2.1K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Replicative Cell Senescence02:15

Replicative Cell Senescence

4.3K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same authorSame journal

Microbial bile acids: Immunomodulatory signals in the tumor microenvironment.

Trends in cancer·2026
Same author

Indole-3-propionic acid.

Trends in endocrinology and metabolism: TEM·2026
Same author

Monoclonal stool antigen test for diagnosing <i>Helicobacter pylori</i> in chronic atrophic gastritis: a prospective primary care study.

Frontiers in cellular and infection microbiology·2026
Same author

The role of gut microbiota in obesity-related cancers.

Seminars in cancer biology·2026
Same author

Microbial metabolites: messengers in the gut-X axis.

Trends in endocrinology and metabolism: TEM·2026
Same author

<i>iMeta</i> Conference 2025: Creating high-impact international journals.

iMeta·2025

相关实验视频

Updated: Jan 16, 2026

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
10:03

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

10.2K

重编程T细胞干细胞对抗癌症

Jiaqi Wang1, Ruochen Yan1, Dingjiacheng Jia2

  • 1Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang Province, 310058, China; Institution of Gastroenterology, Zhejiang University, Hangzhou, Zhejiang Province, 310058, China.

Trends in cancer
|October 3, 2025
PubMed
概括

类似干细胞的CD8+ T细胞,称为原始耗尽的T (Tpex) 细胞,对于持久的抗瘤免疫力至关重要,并且对治疗有很好的反应. 提高它们的茎度为癌症治疗提供了新的可能性.

关键词:
在TCF-1中使用.癌症 癌症 癌症 癌症 癌症我们的肠道微生物群.免疫检查点封锁封锁原始细胞耗尽的T细胞.树干性 树干性

更多相关视频

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

7.3K
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

1.5K

相关实验视频

Last Updated: Jan 16, 2026

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
10:03

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

10.2K
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

7.3K
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

1.5K

科学领域:

  • 免疫学 免疫学 免疫学
  • 在瘤学瘤学.
  • 细胞生物学 细胞生物学

背景情况:

  • 类似干细胞的CD8+ T细胞或原始耗尽的T (Tpex) 细胞,表达TCF-1并且是持久抗瘤免疫力的关键.
  • 这些细胞具有自我更新能力,多效能,并对免疫检查点阻塞疗法的反应得到改善.

研究的目的:

  • 审查目前对Tpex细胞生物学的理解,包括它们的特征,分布和抗瘤免疫中的作用.
  • 探索创新的策略,以保护和增强T细胞干细胞在癌症治疗.

主要方法:

  • 文献综述综合了Tpex细胞生物学的当前研究.
  • 专注于针对T细胞干细胞的新兴治疗方法.

主要成果:

  • Tpex细胞对于对瘤的持续免疫反应至关重要.
  • 各种策略,包括组合疗法,细胞因子调节,表观遗传调节,TME修饰和微生物群干预,可以增强T细胞干细胞性.

结论:

  • 向T细胞干细胞是下一代免疫治疗前沿的前沿.
  • 这些方法具有显著的潜力,可以改善癌症患者的治疗结果.